In the double-blind , placebo-controlled period , patients with active ( mini Bath Ankylosing Spondylitis Disease Activity Index ( BASDAI ) @ ) axSpA despite optimal NSAID intake were randomized to receive etanercept @mg or placebo once weekly for @weeks .